Skip to main content
Premium Trial:

Request an Annual Quote

Epigenetics Feinberg: loss of imprinting increases risk of cancer


Andrew Feinberg, a professor of molecular medicine at Johns Hopkins University, has been having a real chicken-or-the-egg problem in his studies with cancer epigenetics. “One of the puzzling things [in the field] has been how to know what occurs first — whether an epigenetic change arises before the tumor arises or after,” he says.

To get to the bottom of the mystery, Feinberg and his team decided to study epigenetic changes that are present in normal cells and see how it compares to a disorder involving such a change. They homed in on a particular epigenetic change — loss of imprinting — and designed experiments to see how it affected the insulin-like growth factor II, or IGF2, gene often connected with colorectal cancer. “We made a mouse model to test the hypothesis that loss of imprinting really does increase tumor risk,” Feinberg says. The team combined a mouse with loss of imprinting of the gene “with a mouse that’s prone to developing intestinal tumors,” he says. “Basically the mice had both loss of imprinting and a mutation in the APC gene.” As it turns out, mice that had the loss of imprinting had double the likelihood of developing tumors as the other mice.

That study has raised plenty of other questions for Feinberg, who has been studying epigenetic changes for years. “One of the questions that we’re really interested in is which genes are really mediating this,” he says. “We’re … interested in understanding the IGF2 signaling pathway and which particular downstream effects are responsible for this phenotype.”

Feinberg isn’t the only one intrigued by these results. “From the epidemiological community there’s actually a lot of interest” in this kind of work, he says.

— Meredith Salisbury

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.